Literature DB >> 3402740

The development of severe proliferative vitreoretinopathy after retinal detachment surgery. Grade B: a determining risk factor.

M Bonnet1.   

Abstract

A prospective clinical study was conducted to determine wether preoperative proliferative vitreoretinopathy (PVR), grade B, was a significant risk factor in the development of severe PVR after surgery for retinal detachment repair. Two series of consecutive retinal detachments associated with horseshoe retinal tears were compared. The first series included 40 eyes of 40 patients with preoperative PVR, grade O-A. The second series included 30 eyes of 27 patients with preoperative PVR, grade B. All eyes were operated on with conventional microsurgical techniques. At the first operation, no vitrectomies were carried out in any eyes. The incidence of postoperative PVR, grades C and D, was 20% (6/30 eyes) after a single operation in the series of eyes with preoperative PVR, grade B as compared to 0% in the series of eyes with preoperative PVR, grade O-A. The difference between the two groups was statistically significant (P = 0.01). It was also found that the incidence of postoperative proliferative PVR was significantly higher in eyes with preoperative vitreous hemorrhage (30.7%) as compared to eyes with no preoperative vitreous hemorrhage (0%; P = 0.02). Incomplete posterior vitreous detachment without collapse of the vitreous gel occurred significantly more frequently in eyes with preoperative proliferative vitreoretinopathy, grade B (68.4%, than in eyes with preoperative proliferative vitreoretinopathy, grade O-A (27.5%; P = 0.02).

Entities:  

Mesh:

Year:  1988        PMID: 3402740     DOI: 10.1007/bf02181181

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  9 in total

1.  [Retinal detachment caused by small tears in the equatorial region of the retina].

Authors:  M Bonnet; J Urrets-Zavalia
Journal:  J Fr Ophtalmol       Date:  1986       Impact factor: 0.818

2.  Experimental epiretinal proliferation induced by intravitreal red blood cells.

Authors:  B Miller; H Miller; S J Ryan
Journal:  Am J Ophthalmol       Date:  1986-08-15       Impact factor: 5.258

3.  [Retinal detachment caused by a tear at the ora serrata].

Authors:  M Bonnet; P Moyenin; C Pecoldowa; J D Grange
Journal:  J Fr Ophtalmol       Date:  1986       Impact factor: 0.818

4.  Clinical factors predisposing to massive proliferative vitreoretinopathy in rhegmatogenous retinal detachment.

Authors:  M Bonnet
Journal:  Ophthalmologica       Date:  1984       Impact factor: 3.250

5.  Changing concepts of failures after retinal detachment surgery.

Authors:  W F Rachal; T C Burton
Journal:  Arch Ophthalmol       Date:  1979-03

6.  The classification of retinal detachment with proliferative vitreoretinopathy.

Authors: 
Journal:  Ophthalmology       Date:  1983-02       Impact factor: 12.079

7.  Vitreous hemorrhage nontoxic to retina as a stimulator of glial and fibrous proliferation.

Authors:  M Ehrenberg; R J Thresher; R Machemer
Journal:  Am J Ophthalmol       Date:  1984-05       Impact factor: 5.258

8.  [Scleral pocket on the posterior pole and treatment of retinal detachment induced by a macular hole].

Authors:  M Bonnet
Journal:  J Fr Ophtalmol       Date:  1982       Impact factor: 0.818

9.  Severe proliferative vitreoretinopathy and retinal detachment. II. Surgical results with scleral buckling.

Authors:  A Yoshida; P C Ho; C L Schepens; J W McMeel; J E Duncan
Journal:  Ophthalmology       Date:  1984-12       Impact factor: 12.079

  9 in total
  18 in total

1.  Conventional buckling surgery or primary vitrectomy with silicone oil tamponade in rhegmatogenous retinal detachment with multiple breaks.

Authors:  Filiz Afrashi; Tansu Erakgun; Cezmi Akkin; Mahmut Kaskaloglu; Jale Mentes
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-01-09       Impact factor: 3.117

Review 2.  [Scleral buckling surgery and pneumatic retinopexy. Techniques, indications and results].

Authors:  H Hoerauf; H Heimann; L Hansen; H Laqua
Journal:  Ophthalmologe       Date:  2008-01       Impact factor: 1.059

Review 3.  Proliferative Vitreoretinopathy: A Review.

Authors:  Sana Idrees; Jayanth Sridhar; Ajay E Kuriyan
Journal:  Int Ophthalmol Clin       Date:  2019

4.  Surgical risk factors for severe postoperative proliferative vitreoretinopathy (PVR) in retinal detachment with grade B PVR.

Authors:  M Bonnet; S Guenoun
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1995-12       Impact factor: 3.117

5.  Comparison of four surgical techniques for management of pseudophakic and aphakic retinal detachment: a multicenter clinical trial.

Authors:  Siamak Moradian; Hamid Ahmadieh; Hooshang Faghihi; Alireza Ramezani; Morteza Entezari; Touka Banaee; Ebadollah Heidari; Hassan Behboudi; Mehdi Yasseri
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-03-12       Impact factor: 3.117

6.  Risk factors for proliferative vitreoretinopathy after primary vitrectomy: a prospective study.

Authors:  C H Kon; R H Asaria; N L Occleston; P T Khaw; G W Aylward
Journal:  Br J Ophthalmol       Date:  2000-05       Impact factor: 4.638

7.  Prognostic value of new retinal tears associated with the development of postoperative proliferative vitreoretinopathy.

Authors:  J Fleury; M Bonnet
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1992       Impact factor: 3.117

8.  Primary vitrectomy for rhegmatogenous retinal detachment.

Authors:  K N Hakin; M J Lavin; P K Leaver
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1993-06       Impact factor: 3.117

9.  Plasmin is the major protease responsible for processing PDGF-C in the vitreous of patients with proliferative vitreoretinopathy.

Authors:  Hetian Lei; Gisela Velez; Peter Hovland; Tatsuo Hirose; Andrius Kazlauskas
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-01       Impact factor: 4.799

10.  The learning curve for primary vitrectomy without scleral buckling for pseudophakic retinal detachment.

Authors:  Brice Dugas; Pierre-Olivier Lafontaine; Alexandre Guillaubey; Jean-Paul Berrod; Isabelle Hubert; Alain M Bron; Catherine P Creuzot-Garcher
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-11-26       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.